EP3191139
RPGR GENAMEÐFERÐ VIÐ SJÓNUFREKNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.7.2015EP published:
7.10.2020EP application number:
15825383.1
EP translation filed:
10.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
16.7.2035Expiry date:
16.7.2026Next due date:
31.7.2026
Title:
RPGR GENE THERAPY FOR RETINITIS PIGMENTOSA
Timeline
Today
17.7.2015EP application
7.10.2020EP Publication
10.12.2020Translation submitted
15.1.2021Registration published
16.7.2026Expires
Owner
Name:
Massachusetts Eye & Ear InfirmaryAddress:
243 Charles Street, Boston, MA 02114, US
Name:
UCL Business LtdAddress:
The Network Building 97 Tottenham Court Road, London W1T 4TP, GB
Name:
The Government of the United States of America as represented by the Secretary, Department of Health and Human ServicesAddress:
The Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, MD 20892-7660, US
Inventor
Name:
SANDBERG, Michael A.Address:
Reading, Massachusetts 01867, US
Name:
PAWLYK, BasilAddress:
Hampton Falls, New Hampshire 03844, US
Name:
LI, TiansenAddress:
Clarksburg, Maryland 20871, US
Name:
SHU, XinhuaAddress:
Glasgow G76 7XY, GB
Name:
WRIGHT, Alan FinlayAddress:
Edinburgh EH13 0BN, GB
Name:
ALI, RobinAddress:
Clarksburg, Maryland 20871, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201462028638 PDate:
24.7.2014Country:
US
Classification
Categories:
A61K 48/00, C12N 15/861
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 1.7.2021
Expires: 16.7.2022
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 1.7.2022
Expires: 16.7.2023
Payer: Patice ehf.
Number: 9
Paid: 11.7.2023
Expires: 16.7.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 3.7.2024
Expires: 16.7.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 9.7.2025
Expires: 16.7.2026
Payer: Árnason Faktor ehf.